Junevity raises $20M to advance siRNA-based cellular reprogramming
Longevity Technology - 03-Dec-2025siRNA therapy JUN_01 aims to reset metabolic tissues and improve long-term metabolic health
Junevity
Company that focuses on reversing diseases of aging
Junevity is rewinding diseases of aging with novel transcription factor medicines. Based on 6 years of breakthrough research at UCSF, Junevity's REWIND platform identifies new targets based on large-scale genomics, machine learning, and cell aging experiments. Junevity is advancing multiple therapeutic programs towards a new era of rejuvenating medicine.
Visit website: https://www.junevity.com/
Details last updated 17-Mar-2024
Junevity News
Junevity secures $10m to pioneer “cell reset” therapies for longevity
Longevity Technology - 13-Feb-2025Backed by AI and genetics, Junevity targets age-related diseases
Reason reports back from Rejuvenation Startup Summit 2024
Fight Aging! - 13-May-2024A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials
Junevity is also referenced in the following:
Cell Reset Therapeutics to Extend Healthspan and Lifespan (Janine Sengstack, Junevity)
Translating Aging podcast episode-Janine Sengstack explores the use of Cell Reset Therapeutics to improve healthspan
People at Junevity
